These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation. Müller-Steinhardt M; Fricke L; Kirchner H; Hoyer J; Klüter H Clin Transplant; 2000 Feb; 14(1):85-9. PubMed ID: 10693642 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen. Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671 [TBL] [Abstract][Full Text] [Related]
8. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry. Freitas MC Clin Transpl; 2011; ():1-16. PubMed ID: 22755397 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of kidney transplantation from elderly living and expanded criteria deceased donors. Tanrısev M; Hoşcoşkun C; Aşçı G; Sözbilen M; Fırat Ö; Ertilav M; Özkahya M; Töz H Ren Fail; 2015 Mar; 37(2):249-53. PubMed ID: 25470081 [TBL] [Abstract][Full Text] [Related]
10. The impact of late acute rejection after cadaveric kidney transplantation. Joseph JT; Kingsmore DB; Junor BJ; Briggs JD; Mun Woo Y; Jaques BC; Hamilton DN; Jardine AG; Jindal RM Clin Transplant; 2001 Aug; 15(4):221-7. PubMed ID: 11683814 [TBL] [Abstract][Full Text] [Related]
11. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676 [TBL] [Abstract][Full Text] [Related]
12. Dialysis after graft loss: a Swiss experience. Bonani M; Achermann R; Seeger H; Scharfe M; Müller T; Schaub S; Binet I; Huynh-Do U; Dahdal S; Golshayan D; Hadaya K; Wüthrich RP; Fehr T; Segerer S Nephrol Dial Transplant; 2020 Dec; 35(12):2182-2190. PubMed ID: 32170950 [TBL] [Abstract][Full Text] [Related]
13. Surgical complications and cardiovascular comorbidity - Substantial non-immunological confounders of survival after living donor kidney transplantation. Khandoga A; Thomas M; Kleespies A; Kühnke L; Andrassy J; Habicht A; Stangl M; Guba M; Angele M; Werner J; Rentsch M Surgeon; 2019 Apr; 17(2):63-72. PubMed ID: 29861143 [TBL] [Abstract][Full Text] [Related]
14. Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching? Halleck F; Khadzhynov D; Liefeldt L; Schrezenmeier E; Lehner L; Duerr M; Schmidt D; Bamoulid J; Lachmann N; Waiser J; Budde K; Staeck O Nephrol Dial Transplant; 2016 Dec; 31(12):2143-2149. PubMed ID: 27369852 [TBL] [Abstract][Full Text] [Related]
16. Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study. De Sousa-Amorim E; Revuelta I; Blasco M; Diekmann F; Cid J; Lozano M; Sánchez-Escuredo A; Martorell J; Palou E; Campistol JM; Oppenheimer F Transplant Proc; 2015 Oct; 47(8):2332-5. PubMed ID: 26518919 [TBL] [Abstract][Full Text] [Related]
17. Transplant outcomes in kidney recipients with lupus nephritis, and systematic review. Kim JE; Kim YC; Min SL; Lee H; Ha J; Chin HJ; Kim YS; Han SS Lupus; 2020 Mar; 29(3):248-255. PubMed ID: 31996111 [TBL] [Abstract][Full Text] [Related]